What's New

2 November 2022

At the meeting of 4 October 2022 the RMA:

Determined Statements of Principles (SOPs) for:

Condition SOPs
acute stress disorder 95/2022 96/2022
posttraumatic stress disorder 97/2022 98/2022
leptospirosis 101/2022 102/2022
malignant neoplasm of unknown primary site 103/2022 104/2022
pleural plaque 105/2022 106/2022
rotator cuff syndrome 109/2022 110/2022
allergic rhinitis 111/2022 112/2022
restless legs syndrome 113/2022 114/2022

These SOPs revoke the SOPs previously determined for these conditions.

Determined New Statements of Principles (SOPs) for:

Condition SOPs
diaphragmatic hernia 99/2022 100/2022
portal vein thrombosis 107/2022 108/2022

Determined Amendment Statements of Principles (SOPs) for:

Condition SOPs
gingivitis 115/2022 116/2022

The above SOPs take effect from 21 November 2022.

Decided to Undertake Consultation regarding:

Condition Reasons for Decision Date for Final Decision
mitral valve prolapse Intention to remove one or more factors February 2023
chronic obstructive pulmonary disease Intention to remove one or more factors February 2023
periodic limb movement disorder Intention to change one or more factors February 2023

Completed Investigations

The above determinations conclude the previously advertised investigations into:

The above investigation notices appear in the Government Notices Gazette of 1 November 2022.